Clinical Trials
3 trialsNCT05983159 2026-05-05
TARGET-VM
Murdoch Childrens Research Institute
Phase 2 Recruiting
NCT07477548 2026-03-17
A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
Yonsei University
Phase 2 Not yet recruiting
NCT02797366 2016-06-13
PRO-CNS
Uppsala University
Phase 2 Recruiting